Central Vein Sign in Multiple Sclerosis: A Comparison Study of the Diagnostic Performance of 3T versus 7T MRI

REFERENCES

1. 1.↵
   2. Reich DS,
   3. Lucchinetti CF,
   4. Calabresi PA

   . Multiple sclerosis. N Engl J Med 2018;378:169–80 doi:10.1056/NEJMra1401483 pmid:29320652

   CrossRefPubMed
2. 2.↵
   2. Thompson AJ,
   3. Banwell BL,
   4. Barkhof F, et al

   . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

   CrossRefPubMed
3. 3.↵
   2. Sati P,
   3. Oh J,
   4. Constable RT

   , NAIMS Cooperative, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714–22 doi:10.1038/nrneurol.2016.166 pmid:27834394

   CrossRefPubMed
4. 4.↵
   2. Fog T

   . On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand Suppl 1964;40:9–15 doi:10.1111/j.1600-0404.1964.tb04716.x

   CrossRefPubMed
5. 5.↵
   2. Castellaro M,
   3. Tamanti A,
   4. Pisani AI, et al

   . The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis. Diagnostics (Basel) 2020;10:1025 doi:10.3390/diagnostics10121025

   CrossRefPubMed
6. 6.↵
   2. Gaitan MI,
   3. Sati P,
   4. Inati SJ, et al

   . Initial investigation of the blood-brain barrier in MS lesions at 7 Tesla. Mult Scler 2013;19:1068–73 doi:10.1177/1352458512471093 pmid:23246799

   CrossRefPubMed
7. 7.↵
   2. Grabner G,
   3. Dal-Bianco A,
   4. Schernthaner M, et al

   . Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J Magn Reson Imaging 2011;33:543–49 doi:10.1002/jmri.22452 pmid:21563237

   CrossRefPubMed
8. 8.↵
   2. Mistry N,
   3. Dixon J,
   4. Tallantyre E, et al

   . Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. JAMA Neurol 2013;70:623–28 doi:10.1001/jamaneurol.2013.1405 pmid:23529352

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Sinnecker T,
   3. Dorr J,
   4. Pfueller CF, et al

   . Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis. Neurology 2012;79:708–14 doi:10.1212/WNL.0b013e3182648bc8 pmid:22855861

   Abstract/FREE Full Text
10. 10.↵
    2. Tallantyre EC,
    3. Morgan PS,
    4. Dixon JE, et al

    . A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491–94 doi:10.1097/RLI.0b013e3181b4c144 pmid:19652606

    CrossRefPubMed
11. 11.↵
    2. Tallantyre EC,
    3. Dixon JE,
    4. Donaldson I, et al

    . Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology 2011;76:534–39 doi:10.1212/WNL.0b013e31820b7630 pmid:21300968

    Abstract/FREE Full Text
12. 12.↵
    2. Tallantyre EC,
    3. Brookes MJ,
    4. Dixon JE, et al

    . Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076–78 doi:10.1212/01.wnl.0000313377.49555.2e pmid:18505982

    FREE Full Text
13. 13.↵
    2. Wuerfel J,
    3. Sinnecker T,
    4. Ringelstein EB, et al

    . Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 2012;18:1592–99 doi:10.1177/1352458512441270 pmid:22711711

    CrossRefPubMed
14. 14.↵
    2. Hosseini Z,
    3. Matusinec J,
    4. Rudko DA, et al

    . Morphology-specific discrimination between MS white matter lesions and benign white matter hyperintensities using ultra-high-field MRI. AJNR Am J Neuroradiol 2018;39:1473–79 doi:10.3174/ajnr.A5705 pmid:29930096

    Abstract/FREE Full Text
15. 15.↵
    2. Kilsdonk ID,
    3. Wattjes MP,
    4. Lopez-Soriano A, et al

    . Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. Eur Radiol 2014;24:841–49 doi:10.1007/s00330-013-3080-y pmid:24317461

    CrossRefPubMed
16. 16.↵
    2. Dixon JE,
    3. Simpson A,
    4. Mistry N, et al

    . Optimisation of T(2)*-weighted MRI for the detection of small veins in multiple sclerosis at 3 T and 7 T. Eur J Radiol 2013;82:719–27 doi:10.1016/j.ejrad.2011.09.023 pmid:22138119

    CrossRefPubMed
17. 17.↵
    2. Haacke EM,
    3. Mittal S,
    4. Wu Z, et al

    . Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 2009;30:19–30 doi:10.3174/ajnr.A1400 pmid:19039041

    Abstract/FREE Full Text
18. 18.↵
    2. Habek M,
    3. Pavicic T,
    4. Ruska B, et al

    . Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria. Mult Scler Relat Disord 2018;25:99–103 doi:10.1016/j.msard.2018.07.035 pmid:30059896

    CrossRefPubMed
19. 19.↵
    2. Leurs CE,
    3. Twaalfhoven H,
    4. Lissenberg-Witte BI, et al

    . Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study. Mult Scler 2020;26:912–23 doi:10.1177/1352458519845844 pmid:31066634

    CrossRefPubMed
20. 20.↵
    2. Al-Louzi O,
    3. Manukyan S,
    4. Donadieu M, et al

    . Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: an in vivo and postmortem MRI study. Mult Scler 2022;28:1891–902 doi:10.1177/13524585221097560 pmid:35674284

    CrossRefPubMed
21. 21.↵
    2. Wu X,
    3. Ya J,
    4. Zhou D, et al

    . Pathogeneses and imaging features of cerebral white matter lesions of vascular origins. Aging Dis 2021;12:2031–51 doi:10.14336/AD.2021.0414 pmid:34881084

    CrossRefPubMed
22. 22.↵
    2. Absinta M,
    3. Rocca MA,
    4. Colombo B, et al

    . Patients with migraine do not have MRI-visible cortical lesions. J Neurol 2012;259:2695–98 doi:10.1007/s00415-012-6571-x pmid:22714135

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Ng Kee Kwong KC,
    3. Mollison D,
    4. Meijboom R, et al

    . The prevalence of paramagnetic rim lesions in multiple sclerosis: a systematic review and meta-analysis. PLoS One 2021;16:e0256845 doi:10.1371/journal.pone.0256845 pmid:34495999

    CrossRefPubMed
24. 24.↵
    2. Madsen MA,
    3. Wiggermann V,
    4. Bramow S, et al

    . Imaging cortical multiple sclerosis lesions with ultra-high field MRI. Neuroimage Clin 2021;32:102847 doi:10.1016/j.nicl.2021.102847 pmid:34653837

    CrossRefPubMed